NCT00371007已完成2 期
MK0431 Early Phase II Double-blind Study - Type 2 Diabetes Mellitus
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 126
- 主要终点
- HbA1c, safety and tolerability
研究概览
简要总结
A clinical study to determine the safety and efficacy of MK-0431 in patients with Type 2 diabetes mellitus who have inadequate glycemic control on diet/exercise therapy
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 20 Years 至 69 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients have type 2 diabetes mellitus
- •On diet/exercise therapy
排除标准
- •Patients have type 1 diabetes mellitus
结局指标
主要结局
HbA1c, safety and tolerability
次要结局
- Plasma glucose
研究者
相似试验
已完成
3 期
Controlled Study of MK-0431/ONO-5435 in Patients With Type 2 Diabetes MellitusType 2 Diabetes MellitusNCT00363844Ono Pharmaceutical Co. Ltd209
已完成
2 期
A Study of Different Doses of Sitagliptin (MK-0431) in Participants With Type 2 Diabetes Mellitus (MK-0431-014)Type II Diabetes MellitusNCT00481663Merck Sharp & Dohme LLC555
已完成
3 期
MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)Type 2 Diabetes MellitusNCT00372060Merck Sharp & Dohme LLC134
已完成
1 期
An Investigational Drug Study in Adults With Type 2 Diabetes on Basal Insulin (MK-0941-006)Type 2 Diabetes MellitusNCT00511472Merck Sharp & Dohme LLC70
终止
2 期
A Study of LY2409021 in Participants With Type 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT02111096Eli Lilly and Company174